Trials / Completed
CompletedNCT00484016
Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC
Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected Non Small Cell Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 88 Years
- Healthy volunteers
- Not accepted
Summary
There are limited numbers of retrospective studies showing the effectiveness of adjuvant chemotherapy over observation in resected lung cancers.
Detailed description
We propose to retrospectively examine the Washington University School of Medicine experience on all patients receiving adjuvant chemotherapy between 2003 and 2005. We will retrospectively analyze the survival and outcomes in the lung cancer patients receiving adjuvant chemotherapy following surgical resection.
Conditions
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2007-06-08
- Last updated
- 2013-08-13
Source: ClinicalTrials.gov record NCT00484016. Inclusion in this directory is not an endorsement.